Comparison of Time-to-First-Event and Recurrent Event Methods in Multiple Sclerosis Trials
share
Suppression of disability progression is an important goal in the treatment of multiple sclerosis (MS). Randomized clinical trials in MS frequently use the time to the first confirmed disability progression (CDP) on the ordinal Expanded Disability Status Scale (EDSS) as an endpoint. However, especially in progressive forms of MS, patients may experience repeated CDP events over time. We investigate first how recurrent disability progression events can be defined, and consider then recurrent event analyses that could increase power and improve clinical interpretation of results. Data on disease activity and results from two simulation studies which compare analyses of the time to the first event with recurrent event analyses (including negative binomial, Andersen-Gill and Lin-Wei-Ying-Yang models) are presented to demonstrate challenges in defining disability progression and to identify analysis methods suitable for treatment comparisons in MS trials with disability progression endpoints. This article is based on the Master Thesis by Alexandra Būhler at the University of Ulm which was written under the supervision of Jan Beyersmann, Marcel Wolbers, Fabian Model and Qing Wang.
READ FULL TEXT